Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-11

Clinical Trial Update: Analyse the Effect of Semaglutide on Vascular Structure and Function in Patients With Early Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of semaglutide on vascular structure and function in early Type 2 diabetes mellitus. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • semaglutide (semaglutide)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED